SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-24-001946
Filing Date
2024-01-19
Accepted
2024-01-19 17:09:38
Documents
2
Period of Report
2024-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1583
2 POA DOCUMENT poa.txt EX-24 2846
  Complete submission text file 0001209191-24-001946.txt   6033
Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Grossman William (Reporting) CIK: 0001730229 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40431 | Film No.: 24546394

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)